human blood coagulation factor vii

Ukraine

Drugs containing this active substance

PROTHROMPLEX TOTAL

The drug is used for the treatment of bleeding and its prevention before surgery in cases of acquired clotting factor deficiency (e.g., due to the intake of vitamin K antagonists or their overdose), as well as in congenital clotting factor deficiency if specialized products are unavailable.

Form: powder and solvent for injection solution

Active substance	Dosage
human blood coagulation factor ii	375-708 IU
human blood coagulation factor vii	417 IU
human blood coagulation factor ix	500 IU
human blood coagulation factor x	500 IU
protein c	at least 333 IU

ATC: B02BD01

Manufacturer: Takeda Manufacturing Austria AG (batch release; manufacturing, in-process control, batch quality control and stability testing of the medicinal product; labelling, primary and secondary packaging of the medicinal product and diluent; batch quality control and stability testing (Sterility and Bacterial Endotoxins))